The role of otorhinolaryngologists in the treatment of hereditary hemorrhagic telangiectasia
René Lehner, Robin Lochbaum, Thomas K Hoffmann, Jens Greve · 2025
Read The role of otorhinolaryngologists in the treatment of hereditary hemorrhagic telangiectasia by René Lehner, Robin Lochbaum, Thomas K Hoffmann, Jens Greve (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12702161.txt.
Description
Rene Lehner, Robin Lochbaum, Thomas Hoffmann, and Jens Greve weigh the role of ear, nose, and throat doctors in a rare vessel disease in 2025. The disease runs in families, hits vessels body-wide, and most often shows as nosebleeds. Records from one German center span 2006 to 2023.
In the full set of 252 patients, about 43 percent were first treated in the ear, nose, and throat unit, the top share. Its 105 patients also made more visits than other units. Men were more often admitted and given blood. Need for care ran all year, so the team urges joint care paths.
Catalog record
| CREATOR | René Lehner, Robin Lochbaum, Thomas K Hoffmann, Jens Greve |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 21 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |